Who Supplies Doxorubicin? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Doxorubicin exports, with 310+ registered manufacturers shipping to buyers across 136+ countries — yet a handful of companies dominate the shipments. SUN PHARMACEUTICAL INDUSTRIES LIMITED holds the largest share at 23.7% (export value: $15.9M). Close behind, DR.REDDY'S LABORATORIES LTD (4.0%, $2.7M). DR.REDDY'S LABORATORIES LIMITED (3.3%, $2.2M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Doxorubicin? Top Manufacturers & Their Buyers
Flow of Doxorubicin from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Doxorubicin Supplier Network — Key Market Intelligence
The Doxorubicin export market from India is led by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone commands a 23.7% share, shipping $15.9M worth of product across 149 shipments. The second-largest exporter, DR.REDDY'S LABORATORIES LTD, contributes $2.7M (4.0%) to the overall market. Combined, the top two suppliers alone account for 27.6% of all Doxorubicin exports, indicating a relatively concentrated supply base.
Across all 310 tracked manufacturers, the total Doxorubicin export value stands at $67.3M from 3.5K shipments. The market average shipment value is $19.3K. The single largest buyer relationship in terms of trade value is TARO PHARMACEUTICALS INC, receiving $6.9M worth of product.
The combined buyer network spans 19 named purchasing companies, including TARO PHARMACEUTICALS INC, SUN PHARMACEUTICAL INDUSTRIES, INC., RXCROSSROADS 3PL LLC, DR REDDYS LABORATORIES INC, SUDAIR PHARMA UNIT 6 and 14 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1SUN PHARMACEUTICAL INDUSTRIES LIMITED
SUN PHARMACEUTICAL INDUSTRIES LIMITED is the first-largest Doxorubicin exporter from India, with a market share of 23.7% and a total export value of $15.9M across 149 shipments. Their average shipment value of $106.8K is above the market average of $19.3K, suggesting premium or bulk contract pricing.
SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• TARO PHARMACEUTICALS INC — $6.9M across 65 shipments (43.3% of this supplier's total exports)
• SUN PHARMACEUTICAL INDUSTRIES, INC. — $3.2M across 30 shipments (20.2% of this supplier's total exports)
• SUN PHARMACEUTICAL INDUSTRIES, INC. — $2.6M across 24 shipments (16.2% of this supplier's total exports)
• SUN PHARMACEUTICAL INDUSTRIES, INC. — $2.0M across 19 shipments (12.5% of this supplier's total exports)
• RXCROSSROADS 3PL LLC — $1.2M across 12 shipments (7.8% of this supplier's total exports)
Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED's per-shipment value of $106.8K is 455% above the market average of $19.3K, consistent with large-order contracts or value-added formulations.
2DR.REDDY'S LABORATORIES LTD
DR.REDDY'S LABORATORIES LTD is the second-largest Doxorubicin exporter from India, with a market share of 4.0% and a total export value of $2.7M across 51 shipments. Their average shipment value of $52.4K is above the market average of $19.3K, suggesting premium or bulk contract pricing.
DR.REDDY'S LABORATORIES LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• DR REDDYS LABORATORIES INC — $1.0M across 19 shipments (38.1% of this supplier's total exports)
• SUDAIR PHARMA UNIT 6 — $575.7K across 11 shipments (21.6% of this supplier's total exports)
• NORTHSTAR RX LLC — $482.2K across 9 shipments (18.1% of this supplier's total exports)
• INCEPTUA INC C/O J. — $298.9K across 6 shipments (11.2% of this supplier's total exports)
• SAB P.O — $296.9K across 6 shipments (11.1% of this supplier's total exports)
Key Insight: DR.REDDY'S LABORATORIES LTD's per-shipment value of $52.4K is 172% above the market average of $19.3K, consistent with large-order contracts or value-added formulations.
3DR.REDDY'S LABORATORIES LIMITED
DR.REDDY'S LABORATORIES LIMITED is the third-largest Doxorubicin exporter from India, with a market share of 3.3% and a total export value of $2.2M across 10 shipments. Their average shipment value of $218.6K is above the market average of $19.3K, suggesting premium or bulk contract pricing.
DR.REDDY'S LABORATORIES LIMITED serves 4 named buyers in our database. DR REDDYS LABORATORIES INC is the dominant customer, accounting for 60.2% of this supplier's tracked business. Top customers include:
• DR REDDYS LABORATORIES INC — $1.3M across 6 shipments (60.2% of this supplier's total exports)
• SAB P.O BOX67 JEDDAH — $642.0K across 3 shipments (29.4% of this supplier's total exports)
• AMERISOURCE HEALTH S — $194.4K across 1 shipments (8.9% of this supplier's total exports)
• DR. REDDYS LABORATOR — $33.2K across 0 shipments (1.5% of this supplier's total exports)
Key Insight: DR.REDDY'S LABORATORIES LIMITED's per-shipment value of $218.6K is 1035% above the market average of $19.3K, consistent with large-order contracts or value-added formulations.
4DR REDDYS LABORATORIES LIMITED
DR REDDYS LABORATORIES LIMITED is the fourth-largest Doxorubicin exporter from India, with a market share of 3.1% and a total export value of $2.1M across 11 shipments. Their average shipment value of $192.3K is above the market average of $19.3K, suggesting premium or bulk contract pricing.
DR REDDYS LABORATORIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• DR REDDYS LABORATORIES INC — $1.0M across 5 shipments (47.5% of this supplier's total exports)
• NORTHSTAR RX LLC — $716.7K across 4 shipments (33.9% of this supplier's total exports)
• AMERISOURCE HEALTH S — $283.3K across 1 shipments (13.4% of this supplier's total exports)
• INCEPTUA INC C O J K — $85.6K across 0 shipments (4.0% of this supplier's total exports)
• DR REDDYS LABORATORIES INC — $25.4K across 0 shipments (1.2% of this supplier's total exports)
Key Insight: DR REDDYS LABORATORIES LIMITED's per-shipment value of $192.3K is 898% above the market average of $19.3K, consistent with large-order contracts or value-added formulations.
5FRESENIUS KABI ONCOLOGY LIMITED
FRESENIUS KABI ONCOLOGY LIMITED is the fifth-largest Doxorubicin exporter from India, with a market share of 1.9% and a total export value of $1.3M across 143 shipments. Their average shipment value of $8.9K is below the market average of $19.3K, reflecting a high-volume, competitive pricing strategy.
FRESENIUS KABI ONCOLOGY LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• FRESENIUS KABI (THAI — $357.9K across 40 shipments (28.2% of this supplier's total exports)
• FRESENIUS KABI (THAI — $269.4K across 30 shipments (21.2% of this supplier's total exports)
• FRESENIUS KABI (THAI — $254.2K across 29 shipments (20.0% of this supplier's total exports)
• ATCO PHARMA INTERNAT — $208.8K across 23 shipments (16.4% of this supplier's total exports)
• FRESENIUS KABI COLOM — $180.9K across 20 shipments (14.2% of this supplier's total exports)
Key Insight: FRESENIUS KABI ONCOLOGY LIMITED operates with high shipment frequency (143 shipments) at a per-shipment value of $8.9K, indicating a broad distribution network with many smaller, regular orders.
6INTAS PHARMACEUTICALS LIMITED
INTAS PHARMACEUTICALS LIMITED is the fifth-largest Doxorubicin exporter from India, with a market share of 1.4% and a total export value of $917.1K across 393 shipments. Their average shipment value of $2.3K is below the market average of $19.3K, reflecting a high-volume, competitive pricing strategy.
INTAS PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• TO THE ORDER — $449.3K across 193 shipments (49.0% of this supplier's total exports)
• ACCORD FARMACEUTICA — $182.7K across 78 shipments (19.9% of this supplier's total exports)
• ACCORD HEALTHCARE PO — $138.4K across 59 shipments (15.1% of this supplier's total exports)
• brocacef NL HUB — $79.9K across 34 shipments (8.7% of this supplier's total exports)
• XXCORXXHEAXXHCAXX PT — $67.0K across 29 shipments (7.3% of this supplier's total exports)
Key Insight: INTAS PHARMACEUTICALS LIMITED operates with high shipment frequency (393 shipments) at a per-shipment value of $2.3K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Doxorubicin Flows
Once Doxorubicin leaves the manufacturing plants of companies like SUN PHARMACEUTICAL INDUSTRIES LIMITED and DR.REDDY'S LABORATORIES LTD, it travels to 5 destination markets with a combined import value of $67.3M. United States absorbs the largest share at 39.4% ($26.5M), followed by Canada (18.9%) and Mozambique (4.7%).
In United States — the top destination — named importers include DR REDDYS LABORATORIES,INC, SUN PHARMACEUTICAL INDUSTRIES,INC., SUN PHARMACEUTICAL INDUSTRIES INC. In Canada, key buyers are TARO PHARMACEUTICALS INC., TARO PHARMACEUTICALS INC, TARO PHARMACEUTICAL INC..
This geographic spread reflects Doxorubicin's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Doxorubicin Go? Top Importing Countries & Their Buyers
Trade flow of Doxorubicin exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1United States
United States ranks as the first-largest destination for Doxorubicin imports from India, with a total trade value of $26.5M across 102 shipments — representing a 39.4% share of all Doxorubicin exports. The average shipment value of $259.9K is above the global average of $19.3K, indicating high-value procurement contracts or branded formulations. This market is served by 9 tracked buyers.
Named Doxorubicin importers in United States: DR REDDYS LABORATORIES,INC is the largest buyer, accounting for 26.3% ($7.0M) of this market's total imports.
• DR REDDYS LABORATORIES,INC — $7.0M (26.3% of United States's total)
• SUN PHARMACEUTICAL INDUSTRIES,INC. — $3.7M (14.0% of United States's total)
• SUN PHARMACEUTICAL INDUSTRIES INC — $2.7M (10.2% of United States's total)
Key Insight: United States's per-shipment average of $259.9K (1250% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Doxorubicin imports from India.
2Canada
Canada ranks as the second-largest destination for Doxorubicin imports from India, with a total trade value of $12.7M across 15 shipments — representing a 18.9% share of all Doxorubicin exports. The average shipment value of $848.7K is above the global average of $19.3K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Doxorubicin importers in Canada: TARO PHARMACEUTICALS INC. is the largest buyer, accounting for 60.7% ($7.7M) of this market's total imports.
• TARO PHARMACEUTICALS INC. — $7.7M (60.7% of Canada's total)
• TARO PHARMACEUTICALS INC — $2.4M (19.0% of Canada's total)
• TARO PHARMACEUTICAL INC. — $2.4M (18.6% of Canada's total)
Key Insight: Canada's per-shipment average of $848.7K (4306% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Canada is a key market for Doxorubicin imports from India.
3Mozambique
Mozambique ranks as the third-largest destination for Doxorubicin imports from India, with a total trade value of $3.1M across 7 shipments — representing a 4.7% share of all Doxorubicin exports. The average shipment value of $448.2K is above the global average of $19.3K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Doxorubicin importers in Mozambique: MINISTERIO DA SAUDE/ is the largest buyer, accounting for 28.7% ($899.5K) of this market's total imports.
• MINISTERIO DA SAUDE/ — $899.5K (28.7% of Mozambique's total)
• MINISTRIO DA SADE/ — $808.0K (25.8% of Mozambique's total)
Key Insight: Mozambique's per-shipment average of $448.2K (2227% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Mozambique is a key market for Doxorubicin imports from India.
4Vietnam
Vietnam ranks as the fourth-largest destination for Doxorubicin imports from India, with a total trade value of $2.9M across 9 shipments — representing a 4.4% share of all Doxorubicin exports. The average shipment value of $327.5K is above the global average of $19.3K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Doxorubicin importers in Vietnam: HAPHARCO J S C BRANCH is the largest buyer, accounting for 33.9% ($998.5K) of this market's total imports.
• HAPHARCO J S C BRANCH — $998.5K (33.9% of Vietnam's total)
• HAPHARCOJ S CBRANCH — $995.8K (33.8% of Vietnam's total)
• HAPHARCO J.S.C BRANCH — $952.0K (32.3% of Vietnam's total)
Key Insight: Vietnam's per-shipment average of $327.5K (1601% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Vietnam is a key market for Doxorubicin imports from India.
5Saudi Arabia
Saudi Arabia ranks as the fifth-largest destination for Doxorubicin imports from India, with a total trade value of $2.2M across 0 shipments — representing a 3.2% share of all Doxorubicin exports. The average shipment value of $2.2M is above the global average of $19.3K, indicating high-value procurement contracts or branded formulations.
Key Insight: Saudi Arabia's per-shipment average of $2.2M (11176% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Saudi Arabia is a key market for Doxorubicin imports from India.
People Also Ask — Doxorubicin Supplier & Trade Network
Who are the top suppliers of Doxorubicin from India?+
Which companies buy Doxorubicin from Indian manufacturers?+
Where does Doxorubicin exported from India go?+
What is the market share of the top Doxorubicin supplier from India?+
What is the average shipment value for Doxorubicin exports from India?+
Is Doxorubicin manufactured in India and exported globally?+
Which country imports the most Doxorubicin from India?+
Who are the buyers of Doxorubicin in Canada?+
How concentrated is the Doxorubicin supplier market in India?+
How do I find verified buyers for Doxorubicin in specific countries?+
Doxorubicin Trade Network — Key Takeaways
- 1SUN PHARMACEUTICAL INDUSTRIES LIMITED is India's dominant Doxorubicin exporter with a 23.7% market share and $15.9M in total exports — making it the single most important sourcing entity in this market.
- 2The top 310 suppliers collectively account for 37.3% of all tracked Doxorubicin exports, with a combined trade value of $67.3M.
- 3United States is the largest destination market, absorbing 39.4% of India's Doxorubicin exports ($26.5M). Canada (18.9%) and Mozambique (4.7%) follow.
- 4With 3.5K total shipments averaging $19.3K each, the Doxorubicin export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include TARO PHARMACEUTICALS INC, SUN PHARMACEUTICAL INDUSTRIES, INC., DR REDDYS LABORATORIES INC, SUDAIR PHARMA UNIT 6 — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 136 countries
Network value: $67.3M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Doxorubicin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Doxorubicin.
- 2.Flow Mapping: 310 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 3,492 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 136 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
3,492 Verified Shipments
310 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists